• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

儿科基因组学:诊断儿童罕见病。

Paediatric genomics: diagnosing rare disease in children.

机构信息

University of Exeter Medical School, Institute of Biomedical and Clinical Science, Royal Devon and Exeter Hospital, Barrack Road, Exeter EX2 5DW, UK.

Medical Research Council Human Genetics Unit, The Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh EH4 2XU, UK.

出版信息

Nat Rev Genet. 2018 May;19(5):253-268. doi: 10.1038/nrg.2017.116. Epub 2018 Feb 5.

DOI:10.1038/nrg.2017.116
PMID:29398702
Abstract

The majority of rare diseases affect children, most of whom have an underlying genetic cause for their condition. However, making a molecular diagnosis with current technologies and knowledge is often still a challenge. Paediatric genomics is an immature but rapidly evolving field that tackles this issue by incorporating next-generation sequencing technologies, especially whole-exome sequencing and whole-genome sequencing, into research and clinical workflows. This complex multidisciplinary approach, coupled with the increasing availability of population genetic variation data, has already resulted in an increased discovery rate of causative genes and in improved diagnosis of rare paediatric disease. Importantly, for affected families, a better understanding of the genetic basis of rare disease translates to more accurate prognosis, management, surveillance and genetic advice; stimulates research into new therapies; and enables provision of better support.

摘要

大多数罕见病影响儿童,其中大多数患者的疾病都有潜在的遗传原因。然而,利用现有技术和知识做出分子诊断通常仍然是一个挑战。儿科基因组学是一个不成熟但快速发展的领域,它通过将下一代测序技术,特别是外显子组测序和全基因组测序,纳入研究和临床工作流程,来解决这个问题。这种复杂的多学科方法,加上人群遗传变异数据的可用性不断增加,已经导致致病基因的发现率提高,并改善了罕见儿科疾病的诊断。重要的是,对于受影响的家庭来说,对罕见疾病遗传基础的更好理解可转化为更准确的预后、管理、监测和遗传咨询;促进新疗法的研究;并提供更好的支持。

相似文献

1
Paediatric genomics: diagnosing rare disease in children.儿科基因组学:诊断儿童罕见病。
Nat Rev Genet. 2018 May;19(5):253-268. doi: 10.1038/nrg.2017.116. Epub 2018 Feb 5.
2
Opportunities and technical challenges in next-generation sequencing for diagnosis of rare pediatric diseases.下一代测序技术在罕见儿科疾病诊断中的机遇和技术挑战。
Expert Rev Mol Diagn. 2016 Oct;16(10):1073-1082. doi: 10.1080/14737159.2016.1222906. Epub 2016 Aug 25.
3
Genetic diagnosis of developmental disorders in the DDD study: a scalable analysis of genome-wide research data.DDD研究中发育障碍的基因诊断:全基因组研究数据的可扩展分析
Lancet. 2015 Apr 4;385(9975):1305-14. doi: 10.1016/S0140-6736(14)61705-0. Epub 2014 Dec 17.
4
Clinical genomics and contextualizing genome variation in the diagnostic laboratory.临床基因组学与诊断实验室中基因组变异的背景化
Expert Rev Mol Diagn. 2020 Oct;20(10):995-1002. doi: 10.1080/14737159.2020.1826312. Epub 2020 Oct 10.
5
Expediting rare disease diagnosis: a call to bridge the gap between clinical and functional genomics.加速罕见病诊断:呼吁弥合临床与功能基因组学之间的差距。
Mol Med. 2020 Nov 25;26(1):117. doi: 10.1186/s10020-020-00244-5.
6
Implementation of a genomic medicine multi-disciplinary team approach for rare disease in the clinical setting: a prospective exome sequencing case series.在临床环境中实施罕见病基因组医学多学科团队方法:一项前瞻性外显子组测序病例系列研究。
Genome Med. 2019 Jul 25;11(1):46. doi: 10.1186/s13073-019-0651-9.
7
Matching whole genomes to rare genetic disorders: Identification of potential causative variants using phenotype-weighted knowledge in the CAGI SickKids5 clinical genomes challenge.将全基因组与罕见遗传疾病相匹配:在 CAGI SickKids5 临床基因组挑战中使用表型加权知识鉴定潜在的致病变异。
Hum Mutat. 2020 Feb;41(2):347-362. doi: 10.1002/humu.23933. Epub 2019 Nov 15.
8
Identification of genes for childhood heritable diseases.遗传性儿童疾病相关基因的鉴定。
Annu Rev Med. 2014;65:19-31. doi: 10.1146/annurev-med-101712-122108.
9
Diagnosing rare diseases after the exome.外显子组测序后诊断罕见病。
Cold Spring Harb Mol Case Stud. 2018 Dec 17;4(6). doi: 10.1101/mcs.a003392. Print 2018 Dec.
10
Genome Sequencing for Diagnosing Rare Diseases.基因组测序在罕见病诊断中的应用。
N Engl J Med. 2024 Jun 6;390(21):1985-1997. doi: 10.1056/NEJMoa2314761.

引用本文的文献

1
Genetic Variants Linked to Dyslexia Co-Morbid ADHD: A Case Study of a Pakistani Outpatient.与阅读障碍共病注意缺陷多动障碍相关的基因变异:一名巴基斯坦门诊患者的病例研究
J Popul Ther Clin Pharmacol. 2024 Sep 2;31(9):2698-2711. doi: 10.53555/rd5d9s46. Epub 2024 Sep 22.
2
The Solve-RD Solvathons as a pan-European interdisciplinary collaboration to diagnose patients with rare disease.Solve-RD 解决难题马拉松活动是一项泛欧洲的跨学科合作项目,旨在诊断罕见病患者。
Nat Genet. 2025 Sep 9. doi: 10.1038/s41588-025-02290-3.
3
HTA Evidence in Rare Diseases: Just Rare or Also Special?

本文引用的文献

1
Making new genetic diagnoses with old data: iterative reanalysis and reporting from genome-wide data in 1,133 families with developmental disorders.利用旧数据进行新的基因诊断:对 1133 个发育障碍家系的全基因组数据进行迭代重分析和报告。
Genet Med. 2018 Oct;20(10):1216-1223. doi: 10.1038/gim.2017.246. Epub 2018 Jan 11.
2
Clinical detection of deletion structural variants in whole-genome sequences.全基因组序列中缺失结构变异的临床检测。
NPJ Genom Med. 2016 Aug 3;1:16026. doi: 10.1038/npjgenmed.2016.26. eCollection 2016.
3
"Not pathogenic until proven otherwise": perspectives of UK clinical genomics professionals toward secondary findings in context of a Genomic Medicine Multidisciplinary Team and the 100,000 Genomes Project.
罕见病中的卫生技术评估证据:只是罕见还是也很特殊?
Pharmacoeconomics. 2025 Sep 9. doi: 10.1007/s40273-025-01538-4.
4
A cohort of allogeneic hematopoietic stem cell transplantation for pediatric rare diseases (allo-HSCT-PRD): design and preliminary results.儿童罕见病异基因造血干细胞移植队列研究(allo-HSCT-PRD):设计与初步结果
Ann Hematol. 2025 Sep 6. doi: 10.1007/s00277-025-06600-x.
5
Identification of a novel variant (c.778A>G) associated with CHOPS syndrome.一种与CHOPS综合征相关的新型变异体(c.778A>G)的鉴定。
Intractable Rare Dis Res. 2025 Aug 31;14(3):223-231. doi: 10.5582/irdr.2025.01041.
6
Direct connexin-26 interactions with membrane proteins functionally relevant to the cochlea.连接蛋白26与耳蜗功能相关膜蛋白的直接相互作用。
Hum Genet. 2025 Aug 13. doi: 10.1007/s00439-025-02769-3.
7
TRIAGE-GS: protocol for a randomised controlled trial of a genomics-first approach to rare disease diagnosis for patients awaiting assessment by a clinical geneticist.TRIAGE-GS:针对等待临床遗传学家评估的患者,采用基因组学优先方法进行罕见病诊断的随机对照试验方案。
BMJ Open. 2025 Aug 10;15(8):e107603. doi: 10.1136/bmjopen-2025-107603.
8
Genomics on FHIR - a feasibility study to support a National Strategy for Genomic Medicine.基于FHIR的基因组学——一项支持国家基因组医学战略的可行性研究。
NPJ Genom Med. 2025 Jul 29;10(1):57. doi: 10.1038/s41525-025-00516-1.
9
Genetic testing for diagnosing neurodevelopmental disorders and epilepsy: a systematic review and meta-analysis.用于诊断神经发育障碍和癫痫的基因检测:一项系统评价和荟萃分析。
Syst Rev. 2025 Jul 28;14(1):155. doi: 10.1186/s13643-025-02896-y.
10
In Silico Validation of AI-Assisted Drugs in Healthcare.医疗保健中人工智能辅助药物的计算机模拟验证
Methods Mol Biol. 2025;2952:445-458. doi: 10.1007/978-1-0716-4690-8_24.
“除非有证据证明无害”:英国临床基因组学专业人员对基因组医学多学科团队和 10 万基因组计划背景下的次要发现的看法。
Genet Med. 2018 Mar;20(3):320-328. doi: 10.1038/gim.2017.157. Epub 2017 Oct 26.
4
Programmable base editing of A•T to G•C in genomic DNA without DNA cleavage.基因组DNA中A•T到G•C的可编程碱基编辑,无需DNA切割。
Nature. 2017 Nov 23;551(7681):464-471. doi: 10.1038/nature24644. Epub 2017 Oct 25.
5
Tezacaftor-Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508del.Tezacaftor-Ivacaftor 治疗纯合子 Phe508del 突变型囊性纤维化患者的疗效
N Engl J Med. 2017 Nov 23;377(21):2013-2023. doi: 10.1056/NEJMoa1709846. Epub 2017 Nov 3.
6
Nusinersen versus Sham Control in Infantile-Onset Spinal Muscular Atrophy.依库珠单抗治疗婴儿型脊髓性肌萎缩症的疗效观察
N Engl J Med. 2017 Nov 2;377(18):1723-1732. doi: 10.1056/NEJMoa1702752.
7
RNA editing with CRISPR-Cas13.使用CRISPR-Cas13进行RNA编辑。
Science. 2017 Nov 24;358(6366):1019-1027. doi: 10.1126/science.aaq0180. Epub 2017 Oct 25.
8
Use of Exome Sequencing for Infants in Intensive Care Units: Ascertainment of Severe Single-Gene Disorders and Effect on Medical Management.在重症监护病房对婴儿使用外显子组测序:严重单基因疾病的确诊及对医疗管理的影响
JAMA Pediatr. 2017 Dec 4;171(12):e173438. doi: 10.1001/jamapediatrics.2017.3438.
9
Future of Rare Diseases Research 2017-2027: An IRDiRC Perspective.2017 - 2027年罕见病研究的未来:国际罕见病研究协作网观点
Clin Transl Sci. 2018 Jan;11(1):21-27. doi: 10.1111/cts.12500. Epub 2017 Oct 23.
10
Diagnosis of monogenic liver diseases in childhood by next-generation sequencing.通过下一代测序诊断儿童单基因肝病。
Clin Genet. 2018 Mar;93(3):665-670. doi: 10.1111/cge.13120. Epub 2017 Dec 12.